UniProtKB/Swiss-Prot Q9NVI7: Variant p.Gly15Asp

ATPase family AAA domain-containing protein 3A
Gene: ATAD3A
Feedback?

Variant information Variant position:

15 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Aspartate (D) at position 15 (G15D, p.Gly15Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs2274435 [ dbSNP | Ensembl ]

Sequence information Variant position:

15 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

634 The length of the canonical sequence.
Location on the sequence:

MSWLFGINKGPKGE G AGPPPPLPPAQPGAEGGGDR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MSWLFGINKGPKGEGAGPPPPL------PPAQPGAEGGGDR

Xenopus laevis                MSWLFGLNKGQQEPPGVPGFPE------PPSPPGG

Drosophila                    MSWLLGRNRQQPQPDQTAGFSEGGGAADPEGRTAG

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Initiator methionine	1 – 1	Removed
Chain	2 – 634	ATPase family AAA domain-containing protein 3A
Topological domain	2 – 294	Mitochondrial intermembrane
Region	1 – 52	Disordered
Region	2 – 50	Required for interaction with the inner surface of the mitochondrial outer membrane
Modified residue	2 – 2	N-acetylserine
Alternative sequence	1 – 79	Missing. In isoform 3.

Literature citations
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2); VARIANT ASP-15;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.